Item Type | Name |
Concept
|
Antigen-Presenting Cells
|
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Antigen Presentation
|
Concept
|
B7-1 Antigen
|
Concept
|
B7-H1 Antigen
|
Concept
|
CD47 Antigen
|
Concept
|
CTLA-4 Antigen
|
Concept
|
gp100 Melanoma Antigen
|
Concept
|
B7-2 Antigen
|
Concept
|
MART-1 Antigen
|
Concept
|
Receptors, Antigen, T-Cell
|
Academic Article
|
Differential regulation of murine T lymphocyte subsets.
|
Academic Article
|
Differential function of intestinal intraepithelial lymphocyte subsets.
|
Academic Article
|
B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
|
Academic Article
|
Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
|
Academic Article
|
Liver of MRL/lpr mice contain interleukin-4-producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones.
|
Academic Article
|
Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.
|
Academic Article
|
Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.
|
Academic Article
|
Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
|
Academic Article
|
The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
|
Academic Article
|
Blocked Ras activation in anergic CD4+ T cells.
|
Academic Article
|
Rational development of tumour antigen-specific immunization in melanoma.
|
Academic Article
|
Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity.
|
Academic Article
|
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
|
Academic Article
|
Biochemical analysis of activated T lymphocytes. Protein phosphorylation and Ras, ERK, and JNK activation.
|
Academic Article
|
B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
|
Academic Article
|
Antigen-specific blockade of T cells in vivo using dimeric MHC peptide.
|
Academic Article
|
CD28 is not required for c-Jun N-terminal kinase activation in T cells.
|
Academic Article
|
Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12.
|
Academic Article
|
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
|
Academic Article
|
Transplantation and the CD28/CTLA4/B7 pathway.
|
Academic Article
|
Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12.
|
Academic Article
|
Differential activation of murine TH1 and TH2 clones.
|
Academic Article
|
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.
|
Academic Article
|
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.
|
Academic Article
|
Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.
|
Academic Article
|
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.
|
Academic Article
|
Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A.
|
Academic Article
|
Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes.
|
Academic Article
|
Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells.
|
Academic Article
|
Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration.
|
Academic Article
|
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
|
Academic Article
|
Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.
|
Academic Article
|
Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
|
Academic Article
|
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
|
Academic Article
|
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901.
|
Academic Article
|
Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones.
|
Academic Article
|
Cutting edge: cytotoxic granule polarization and cytolysis can occur without central supramolecular activation cluster formation in CD8+ effector T cells.
|
Academic Article
|
Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection.
|
Academic Article
|
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
|
Academic Article
|
The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
|
Academic Article
|
Negative regulation of T-cell function by PD-1.
|
Academic Article
|
Protein kinase Ctheta focusing at the cSMAC is a consequence rather than cause of TCR signaling and is dependent on the MEK/ERK pathway.
|
Academic Article
|
Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
|
Academic Article
|
Costimulatory and coinhibitory receptors in anti-tumor immunity.
|
Academic Article
|
Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
|
Academic Article
|
Nakahara memorial lecture. Regulation of T lymphocyte responses: interactions among receptors.
|
Academic Article
|
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo.
|
Academic Article
|
Evidence implicating I region-restricted antigen presentation in alloantigen and nominal antigen recognition by a dual-reactive helper T lymphocyte clone.
|
Academic Article
|
Murine hepatic accessory cells support the proliferation of Th1 but not Th2 helper T lymphocyte clones.
|
Academic Article
|
Regulation of T-cell activation: differences among T-cell subsets.
|
Academic Article
|
Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.
|
Academic Article
|
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
|
Academic Article
|
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
|
Academic Article
|
Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes.
|
Academic Article
|
Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1.
|
Academic Article
|
Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways.
|
Academic Article
|
The expanding universe of regulatory T cell subsets in cancer.
|
Academic Article
|
An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.
|
Academic Article
|
"Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype.
|
Academic Article
|
Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-?1 phosphorylation.
|
Academic Article
|
Control of T lymphocyte signal transduction through clonal anergy.
|
Academic Article
|
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
|
Academic Article
|
Expression and function of CTLA-4 in Th1 and Th2 cells.
|
Academic Article
|
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
|
Academic Article
|
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.
|
Academic Article
|
Formation of a central supramolecular activation cluster is not required for activation of naive CD8+ T cells.
|
Academic Article
|
Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma.
|
Academic Article
|
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.
|
Academic Article
|
Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.
|
Academic Article
|
CD40 ligation reverses T cell tolerance in acute myeloid leukemia.
|
Academic Article
|
Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses.
|
Academic Article
|
Therapeutic activity of high-dose intratumoral IFN-ß requires direct effect on the tumor vasculature.
|
Academic Article
|
Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction.
|
Academic Article
|
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
|
Academic Article
|
Innate immune recognition of cancer.
|
Academic Article
|
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
|
Academic Article
|
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.
|
Academic Article
|
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
|
Academic Article
|
Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy.
|
Academic Article
|
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
|
Academic Article
|
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA.
|
Academic Article
|
MYC - a thorn in the side of cancer immunity.
|
Academic Article
|
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
|
Academic Article
|
The composition of the microbiota modulates allograft rejection.
|
Academic Article
|
The host STING pathway at the interface of cancer and immunity.
|
Academic Article
|
NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.
|
Academic Article
|
The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment.
|
Academic Article
|
Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity.
|
Academic Article
|
High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions.
|
Academic Article
|
Secondary resistance to immunotherapy associated with ß-catenin pathway activation or PTEN loss in metastatic melanoma.
|
Academic Article
|
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
|
Academic Article
|
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-?-signaling mutant cancer cells.
|
Academic Article
|
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
|
Academic Article
|
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines.
|
Concept
|
Histocompatibility Antigen H-2D
|
Academic Article
|
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
|
Academic Article
|
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy.
|